Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression

Internal and Emergency Medicine

Volumn 8, Issue 6, 2013, Pages 485-491

  Atteritano, Marco ^a   Lasco, Antonino ^a   Mazzaferro, Susanna ^a   Macrì, Ida ^a   Catalano, Antonino ^a   Santangelo, Antonino ^b   Bagnato, Gianluca ^a   Bagnato, Gianfilippo ^a   Frisina, Nicola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bone; Cytokine; Depression; Menopause; Parathyroids

Indexed keywords

COLECALCIFEROL; PARATHYROID HORMONE;

ARTICLE; BLOOD; BONE DENSITY; BONE REMODELING; CALCANEUS; COMORBIDITY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FINGER PHALANX; HUMAN; MAJOR DEPRESSION; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE; RISK FACTOR;

BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CALCANEUS; CHOLECALCIFEROL; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; FEMALE; FINGER PHALANGES; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; RISK FACTORS;

EID: 84883653127     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0628-1     Document Type: Article

References (33)

1. Ross PD (1996) Osteoporosis. Frequency, consequences, and risk factors. Arch Intern Med 156(13): 1399-1411.
2. van Vort WB, Rubenstein M, Rose RP (1990) Osteoporosis with pathological hip fractures in major depression. J Geriatr Psychiatry Neurol 3: 10-12.
3. Halbreich U, Palter S (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiologic processes. Schizophr Bull 22: 447-454.
4. Cizza G, Ravn P, Chrousos GP, Gold PW (2001) Depression: a major, unrecognized risk factor for osteoporosis. Trends Endocrinol Metab 12: 198-203.
5. Varga E, Csaba G, Holló I, Koref O (1968) Androgen deficit and osteoporosis in depressed female patients. Act Nerv Super 10: 12-14.
6. Schweiger U, Deuschle M, Körner A et al (1994) Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 151: 1691-1693.
7. Michelson D, Stratakis C, Hill L et al (1996) Bone mineral density in women with depression. N Engl J Med 335: 1176-1182.
8. Schweiger U, Weber B, Deuschle M, Heuser I (2000) Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow up. Am J Psychiatry 157: 118-120.
9. Robbins J, Hirsch C, Whitmer R, Cauley J, Harris T (2001) The association of bone mineral density and depression in an older population. J Am Geriatr Soc 49: 732-736.
10. Mussolino ME (2005) Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep 120: 71-75.
11. Jacka FN, Pasco JA, Henry MJ et al (2005) Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 12: 88-91.
12. Ozsoy S, Eşel E, Turan MT et al (2005) Is there any alteration in bone mineral density in patients with depression? Turk Psikiyatri Derg 16: 77-82.
13. Reginster JY, Deroisy R, Paul I, Hansenne M, Ansseau M (1999) Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 33: 133-137.
14. Whooley MA, Cauley JA, Zmuda JM, Haney EM, Glynn NW (2004) Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 17: 88-92.
15. Yazici AE, Bagis S, Tot S, Sahin G, Yazici K, Erdogan C (2005) Bone mineral density in premenopausal women with major depression. Joint Bone Spine 72: 540-543.
16. Wong SY, Lau EM, Lynn H et al (2005) Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int 16(6): 610-615.
17. Hofbauer LC, Heufelder AE (2000) The role of receptor activator of nuclear factor- B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85: 2355-2363.
18. Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
19. Li J, Sarosi I, Yan XQ et al (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97: 1566-1571.
20. Wu Q, Magnus JH, Liu J, Bencaz AF, Hentz JG (2009) Depression and low bone mineral density: a meta-analysis of epidemiologic studies. Osteoporos Int 20(8): 1309-1320.
21. Murphy PK, Wagner CL (2008) Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health 53(5): 440-446.
22. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med Dec 264(6): 599-609.
23. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2): 317-322 Review.
24. Lips P, Duong T, Oleksik A et al (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcome of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86(3): 1212-1221.
25. Kahl KG, Rudolf S, Dibbelt L et al (2005) Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. Osteoporos Int 16(4): 424-429.
26. Petronijević M, Petronijević N, Ivković M et al (2008) Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 42(3): 582-590.
27. Lee SK, Lorenzo JA (1999) Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140(8): 3552-3561.
28. van Craenenbroeck K, De Bosscher K, Vanden Berghe W, Vanhoenacker P, Haegeman G (2005) Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol Cell Endocrinol 1-2: 10-22 Review.
29. Pariante CM, Papadopoulos AS, Poon L et al (2002) A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biol Psychiatry 51(11): 922-930.
30. Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M (2004) Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos Int 15(11): 855-861.
31. Borer KT (2005) Physical activity in the prevention and amelioration of osteoporosis in women: interaction of mechanical, hormonal and dietary factors. Sports Med 35(9): 779-830 Review.
32. Diem SJ, Blackwell TL, Stone KL et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12): 1240-1245.
33. Haney EM, Chan BK, Diem SJ, Osteoporotic Fractures in Men Study Group et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167(12): 1246-1251.